Cell Therapeutics Inc. (CTIC) Reports Q1 Loss of $0.20

April 29, 2014 4:51 PM

Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q1 EPS of ($0.20), versus ($0.18) reported last year. Revenue for the quarter came in at $1.4 million, versus $1.1 million reported last year.

For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.

Categories

Earnings